Vepafestinib: a RET-selective inhibitor with enhanced CNS penetrance targets therapy-resistant mutants
Crossref DOI link: https://doi.org/10.1038/s43018-023-00631-x
Published Online: 2023-09-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining valid from 2023-09-21
Version of Record valid from 2023-09-21
Article History
First Online: 21 September 2023